Valuation OneSource Specialty Pharma Limited
Stocks
ONESOURCE
INE013P01021
Biotechnology & Medical Research
|
Market Closed -
NSE India S.E.
04:35:09 01/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 1,508.00 INR | -0.89% |
|
-5.56% | -16.71% |
Company Valuation: OneSource Specialty Pharma Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| Market Cap 1 | 2,00,521 | 1,68,871 | 1,72,886 | - | - |
| Change | - | -15.78% | 2.38% | - | - |
| Enterprise Value (EV) 1 | 2,00,521 | 1,80,604 | 1,81,742 | 1,74,050 | 1,72,886 |
| Change | - | -9.93% | 0.63% | -4.23% | -0.67% |
| P/E | -1,075x | -229x | 37.2x | 18x | - |
| PBR | - | - | 2.75x | 2.43x | 2.37x |
| PEG | - | -1x | -0x | 0x | - |
| Capitalization / Revenue | - | 11.9x | 7.93x | 5.08x | 5.81x |
| EV / Revenue | - | 12.7x | 8.34x | 5.12x | 5.81x |
| EV / EBITDA | - | 59.4x | 23.1x | 12.7x | 15x |
| EV / EBIT | - | 719x | 32.9x | 16.9x | 20.4x |
| EV / FCF | - | -32.2x | 32.8x | 23.2x | 22.3x |
| FCF Yield | - | -3.1% | 3.04% | 4.3% | 4.48% |
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -1.63 | -6.44 | 40.5 | 83.73 | - |
| Distribution rate | - | - | - | - | - |
| Net sales 1 | - | 14,216 | 21,798 | 34,019 | 29,769 |
| EBITDA 1 | - | 3,042 | 7,875 | 13,689 | 11,544 |
| EBIT 1 | - | 251.3 | 5,526 | 10,322 | 8,472 |
| Net income 1 | -179.7 | -738 | 4,459 | 8,968 | 7,308 |
| Net Debt 1 | - | 11,733 | 8,856 | 1,164 | - |
| Reference price 2 | 1,752.25 | 1,473.30 | 1,508.00 | 1,508.00 | 1,508.00 |
| Nbr of stocks (in thousands) | 1,14,436 | 1,14,621 | 1,14,646 | - | - |
| Announcement Date | 05/05/25 | 13/05/26 | - | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 37.57x | 8.41x | 23.28x | - | 181.94Cr | |
| 21.73x | 7.77x | 15.61x | 1.37% | 7.45TCr | |
| 31.25x | 9.01x | 28.06x | 0.04% | 6.01TCr | |
| 33.64x | 6.03x | 18.07x | 0.97% | 4.82TCr | |
| 34.63x | 3.34x | 14.4x | -.--% | 4.43TCr | |
| -21.16x | 229.18x | -22.81x | -.--% | 4.4TCr | |
| 47.94x | 5.54x | 30.43x | -.--% | 4.16TCr | |
| 26.89x | 7.76x | 19.96x | 0.42% | 3TCr | |
| 33.91x | 7.26x | 18.84x | -.--% | 2.93TCr | |
| -70.02x | 13.44x | -68.51x | -.--% | 2.49TCr | |
| Average | 17.64x | 29.77x | 7.73x | 0.31% | 3.99TCr | |
| Weighted average by Cap. | 19.66x | 31.78x | 10.30x | 0.41% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ONESOURCE Stock
- Valuation OneSource Specialty Pharma Limited
Select your edition
All financial news and data tailored to specific country editions
